Shaffer et al v. Purdue Pharma L.P. et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:18-op-46302 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | No cause code entered |
| Case Filed: | Dec 10, 2018 |
| Case in other court: | West Virginia Southern, 2:18-cv-01448 |
| Last checked: Friday Nov 08, 2019 7:04 PM EST |
|
Defendant
Mallinckrodt PLC
|
|
|
Defendant
Watson Pharmaceuticals, Inc.
|
|
|
Defendant
Watson Laboratories Inc.
|
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
|
|
|
Defendant
R.C. Son & R.C. Son
|
|
|
Defendant
Purdue Pharma L.P.
|
|
|
Defendant
Purdue Pharma Inc.
|
|
|
Defendant
Purdue Frederick Company, Inc.
|
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
|
|
|
Defendant
Noramco Inc
|
|
|
Defendant
McKesson Corporation
|
Represented By
|
|
Defendant
Mallinckrodt LLC
|
|
|
Defendant
Johnson & Johnson
|
|
|
Defendant
Janssen Pharmaceutica Inc.
|
|
|
Defendant
Endo Pharmaceuticals Inc.
|
|
|
Defendant
Endo Health Solutions Inc.
|
|
|
Defendant
Cephalon Inc.
|
|
|
Defendant
Cardinal Health Inc.
|
|
|
Defendant
AmerisourceBergen Drug Corporation
|
|
|
Defendant
Allergan PLC
|
|
|
Defendant
Actavis Pharma, Inc.
|
|
|
Defendant
Actavis LLC
|
|
|
Plaintiff
R. C.
|
Represented By
|
|
Plaintiff
Jodi Shaffer
|
Represented By
|
| Docket last updated: 04/08/2019 6:55 PM EDT |
| Thursday, November 15, 2018 | ||
| 1 | 1
21
pgs
CLASS ACTION COMPLAINT. Filing Fee $400.00. Receipt # AWVSDC-6958891. (taq) [Transferred from wvsd on 12/10/2018.]
|
|
|
Att: 1
22 pgs
Continuation Part 2,
|
||
|
Att: 2
23 pgs
Continuation Part 3,
|
||
|
Att: 3
26 pgs
Continuation Part 4,
|
||
|
Att: 4
4 pgs
Continuation Part 5,
|
||
|
Att: 5
Civil Cover Sheet
|
||
| 2 | 2
SUMMONS SUBMITTED by Jodi Shaffer, R. C. for Actavis LLC, Actavis Pharma, Inc., Allergan PLC, AmerisourceBergen Drug Corporation, Cardinal Health, Inc., Cephalon, Inc., Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceutica Inc., Johnson & Johnson, Mallinckrodt, LLC, Mallinckrodt, PLC, McKesson Corporation, Noramco, Inc., Ortho-McNeil-Jannsen Pharmaceuticals, Inc., Purdue Pharma L.P., Purdue Pharma, Inc., R.C. Son & R.C. Son, Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals, USA, Inc., The Purdue Frederick Company, Inc., Watson Laboratories, Inc., Watson Pharmaceuticals, Inc., re:1 Class Action Complaint. (taq) [Transferred from wvsd on 12/10/2018.]
|
|
| Friday, November 16, 2018 | ||
| 3 | 3
STANDING ORDER IN RE: ASSIGNMENT AND REFERRAL OF CIVIL ACTIONS AND MATTERS TO MAGISTRATE JUDGES ENTERED JANUARY 4, 2016. Discovery referred to Magistrate Judge Aboulhosn. (cc: attys; any unrepresented party) (taq) [Transferred from wvsd on 12/10/2018.]
|
|
| 4 | 4
ELECTRONIC SUMMONS ISSUED as to Actavis LLC, Actavis Pharma, Inc., Allergan PLC, AmerisourceBergen Drug Corporation, Cardinal Health, Inc., Cephalon, Inc., Endo Health Solutions Inc., Endo Pharmaceuticals Inc., Janssen Pharmaceutica Inc., Johnson & Johnson, Mallinckrodt, LLC, Mallinckrodt, PLC, McKesson Corporation, Noramco, Inc., Ortho-McNeil-Jannsen Pharmaceuticals, Inc., Purdue Pharma L.P., Purdue Pharma, Inc., R.C. Son & R.C. Son, Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals, USA, Inc., The Purdue Frederick Company, Inc., Watson Laboratories, Inc., Watson Pharmaceuticals, Inc., re:1 Class Action Complaint. Summons returnable 21 days. Instructions to Counsel: This is your electronic summons. Please print as many copies of the Summons and Complaint as are necessary to effectuate service under Fed. R. Civ. P. 4. See Proof of Service page of this Summons form for filing a return of service if required by Fed. R. Civ. P. 4(l). (taq) [Transferred from wvsd on 12/10/2018.]
|
|
|
Att: 1
Summons issued as to The Purdue Frederick Company,
|
||
|
Att: 2
Summons issued as to Purdue Pharma,
|
||
|
Att: 3
Summons issued as to McKesson Corporation,
|
||
|
Att: 4
Summons issued as to Cardinal Health,
|
||
|
Att: 5
Summons issued as to Noramco,
|
||
|
Att: 6
Summons issued as to Mallinckrodt PLC,
|
||
|
Att: 7
Summons issued as to Mallinckrodt LLC,
|
||
|
Att: 8
Summons issued as to AmerisourceBergen,
|
||
|
Att: 9
Summons issued as to Teva Pharmaceutical Industries, Ltd.,
|
||
|
Att: 10
Summons issued as to Teva Pharmaceuticals, USA, Inc.,
|
||
|
Att: 11
Summons issued as to Cephalon, Inc.,
|
||
|
Att: 12
Summons issued as to Johnson & Johnson,
|
||
|
Att: 13
Summons issued as to Janssen Pharmaceuticals, Inc.,
|
||
|
Att: 14
Summons issued as to Ortho-McNeil-Jannsen Pharmaceuticals, Inc.,
|
||
|
Att: 15
Summons issued as to Janssen Pharmaceutica Inc.,
|
||
|
Att: 16
Summons issued as to Endo Health Solutions Inc.,
|
||
|
Att: 17
Summons issued as to Endo Pharmaceuticals Inc.,
|
||
|
Att: 18
Summons issued as to Allergan PLC,
|
||
|
Att: 19
Summons issued as to Watson Pharmaceuticals, Inc.,
|
||
|
Att: 20
Summons issued as to Watson Laboratories, Inc.,
|
||
|
Att: 21
Summons issued as to Actavis, LLC,
|
||
|
Att: 22
Summons issued as to Actavis Pharma, Inc.
|
||
| Thursday, December 06, 2018 | ||
| 5 | 5
NOTIFICATION FROM JUDICIAL PANEL ON MULTIDISTRICT LITIGATION re: Conditional Transfer Order (CTO-69), MDL 2804. (kp) [Transferred from wvsd on 12/10/2018.]
|
|
| Monday, December 10, 2018 | ||
| 6 | 6
CONDITIONAL TRANSFER ORDER (CTO-69) JUDICIAL PANEL ON MDL: certified copy from the Northern District of Ohio transferring this action to the USDC/NDOH for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C. § 1407. Signed by Jeffery N. Luthi, Clerk of the Panel on 12/10/2018. (cc: attys) (kp) [Transferred from wvsd on 12/10/2018.]
|
|
| 7 | 7
CASE TRANSFERRED IN from District of West Virginia Southern. Case number 2:18-cv-01448. Original file, certified copy of transfer order and docket sheet received.
|
|